Similar companies
Income Statement (USD)
| Q4 '25 | QoQ | |
|---|---|---|
| Revenue | 19.3B | 9.6% |
| Gross Profit | 16.4B | 12.4% |
| Cost of Revenue | 2.88B | 4.1% |
| Operating expense | 7.63B | 23% |
| Net Income | 6.64B | 18.9% |
| EBITDA | 8.39B | 6.4% |
Balance Sheet (USD)
| Q4 '25 | QoQ | |
|---|---|---|
| Shares Outstanding | 898M | 0.1% |
Cash Flow (USD)
| Q4 '25 | QoQ |
|---|
EPS
Financial Highlights for Eli Lilly and Company in Q4 '25
Eli Lilly and Company reported a revenue of 19.3B, which is a 9.6% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 16.4B, marking a 12.4% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 2.88B, a -4.1% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 7.63B, showing a 23% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 6.64B, showing a 18.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 8.39B, showing a 6.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Eli Lilly and Company with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
